Influence of pallet rich plasma, quercetin and their combination on activity of nitric oxide cycle enzymes in nasal mucosa of patients with atrophic rhinitis.

Q3 Medicine
Ruslan V Bondarenko, Sergey B Bezshapochnyy, Mychailo I Bezega, Valerii V Loburets, Vitilii O Kostenko, Oleh Ye Akimov, Alevtyna M Bilous
{"title":"Influence of pallet rich plasma, quercetin and their combination on activity of nitric oxide cycle enzymes in nasal mucosa of patients with atrophic rhinitis.","authors":"Ruslan V Bondarenko, Sergey B Bezshapochnyy, Mychailo I Bezega, Valerii V Loburets, Vitilii O Kostenko, Oleh Ye Akimov, Alevtyna M Bilous","doi":"10.36740/Merkur202401103","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Aim: To study the general activity of NO synthases (gNOS), the activity of inducible and constitutive isoforms of NO synthase, the activity of arginases, and the concentration of nitrites in the nasal mucosa under the conditions of local treatment of chronic atrophic rhinitis (AR) with quercetin and platelet-rich plasma (PRP therapy)..</p><p><strong>Patients and methods: </strong>Materials and Methods: The study was conducted on 118 patients divided into two groups: control (n=20) and experimental (patients with AR, n=98). Experimental group was divided into 4 subgroups: standard treatment (n=29), PRP therapy (6 injections for 28 day course, n=19), Quercetin (40 mg 3 times a day for 28 days, n=26) and PRP+Quercetin (n=24) groups.</p><p><strong>Results: </strong>Results: Standard therapy of SaR increases gNOS by 278.38% and arginase activity increases by 222.73%. PRP therapy increases gNOS by 211.43% and arginase by 540.91%. Quercetin elevates gNOS by 108.33% and arginase by 250%. PRP therapy and quercetin increases gNOS by 146.15% and arginase by 536.36%.</p><p><strong>Conclusion: </strong>Conclusions: The use of standard therapy of SaR and addition of PRP therapy, quercetin and their combination effectively restores the production of nitric oxide and the arginase activity in the nasal mucosa.</p>","PeriodicalId":39518,"journal":{"name":"Polski Merkuriusz Lekarski","volume":"52 1","pages":"17-22"},"PeriodicalIF":0.0000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Polski Merkuriusz Lekarski","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.36740/Merkur202401103","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: Aim: To study the general activity of NO synthases (gNOS), the activity of inducible and constitutive isoforms of NO synthase, the activity of arginases, and the concentration of nitrites in the nasal mucosa under the conditions of local treatment of chronic atrophic rhinitis (AR) with quercetin and platelet-rich plasma (PRP therapy)..

Patients and methods: Materials and Methods: The study was conducted on 118 patients divided into two groups: control (n=20) and experimental (patients with AR, n=98). Experimental group was divided into 4 subgroups: standard treatment (n=29), PRP therapy (6 injections for 28 day course, n=19), Quercetin (40 mg 3 times a day for 28 days, n=26) and PRP+Quercetin (n=24) groups.

Results: Results: Standard therapy of SaR increases gNOS by 278.38% and arginase activity increases by 222.73%. PRP therapy increases gNOS by 211.43% and arginase by 540.91%. Quercetin elevates gNOS by 108.33% and arginase by 250%. PRP therapy and quercetin increases gNOS by 146.15% and arginase by 536.36%.

Conclusion: Conclusions: The use of standard therapy of SaR and addition of PRP therapy, quercetin and their combination effectively restores the production of nitric oxide and the arginase activity in the nasal mucosa.

富集托盘血浆、槲皮素及其组合对萎缩性鼻炎患者鼻粘膜一氧化氮循环酶活性的影响
研究目的目的:研究在槲皮素和富血小板血浆(PRP疗法)局部治疗慢性萎缩性鼻炎(AR)的条件下,鼻粘膜中NO合酶(gNOS)的一般活性、NO合酶的诱导型和组成型同工酶的活性、精氨酸酶的活性以及亚硝酸盐的浓度:材料和方法:研究对象为 118 名患者,分为两组:对照组(20 人)和实验组(AR 患者,98 人)。实验组分为 4 个亚组:标准治疗组(n=29)、PRP 治疗组(6 次注射,28 天为一疗程,n=19)、槲皮素治疗组(40 毫克,每天 3 次,28 天为一疗程,n=26)和 PRP+ 槲皮素治疗组(n=24):结果:结果:SaR标准疗法可使gNOS增加278.38%,精氨酸酶活性增加222.73%。PRP疗法可使gNOS增加211.43%,精氨酸酶增加540.91%。槲皮素能使 gNOS 增加 108.33%,使精氨酸酶增加 250%。PRP 疗法和槲皮素可使 gNOS 增加 146.15%,使精氨酸酶增加 536.36%:结论:结论:使用 SaR 标准疗法和 PRP疗法、槲皮素及其组合疗法可有效恢复鼻黏膜一氧化氮的生成和精氨酸酶的活性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Polski Merkuriusz Lekarski
Polski Merkuriusz Lekarski Medicine-Medicine (all)
CiteScore
1.90
自引率
0.00%
发文量
84
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信